CHICAGO — In this video, Erika P. Hamilton, MD, discusses results from the HER2CLIMB-05 trial of tucatinib in combination with trastuzumab and pertuzumab as first-line maintenance therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results